Board of Directors

Helen S. Kim, Board Chairman

Managing Director, Vida Ventures

Helen S. Kim, M.B.A., joined our board of directors in August 2018, bringing with her over 27 years of leadership experience in biotechnology. Ms. Kim currently serves as managing director of Vida Ventures, a position she has held since April 2019. From March 2018 to March 2019, Ms. Kim served as a partner at The Column | READ MORE

David Lamond

President, En Pointe LLC

David A. Lamond joined our board of directors in September 2018. Since April 2016, Mr. Lamond has served as president of En Pointe LLC, an investment firm. From 2011 to 2016, he served as the president, chief executive officer and chief investment officer of Lamond Capital Partners LLC. | READ MORE

Tahir Mahmood, PhD

Chief Executive Officer & Co-founder

Tahir co-founded AMT, where he has overseen the company’s growth from concept to clinical trials in patients through multiple equity financing rounds. He was closely involved in the early development of the technology and also led the company’s partnering and corporate development activities. | READ MORE

Randall Mrsny, PhD

Chief Science Officer & Co-founder

An epithelial biologist, Randy has more than three decades of industry and academic experience in pharmaceutical sciences and research into the mucosal trafficking of peptide and protein therapeutics.  | READ MORE

Aaron VanDevender

Chief Scientist and Principal, Founders Fund

Aaron VanDevender, Ph.D., joined our board of directors in November 2016. Since 2012, Dr. VanDevender has served as chief scientist and principal at Founders Fund.  From October 2010 to March 2012, Dr. VanDevender served as a physicist at Halcyon Molecular, a company focused on next-generation DNA sequencing technology. | READ MORE